Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
11/30/2006 | US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
11/30/2006 | DE69735603T2 PTHrP Analogen PTHrP analogs |
11/30/2006 | CA2613337A1 Nk-b inhibitors for the treatment of muscular dystrophy |
11/30/2006 | CA2609446A1 Activator for peroxisome proliferator-activated receptor |
11/30/2006 | CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same |
11/29/2006 | EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
11/29/2006 | EP1726592A1 Dioxino derivatives and their use as dopanine agonists |
11/29/2006 | EP1726590A1 Cycloalkanopyridine derivative |
11/29/2006 | EP1726587A1 Benzothiazin-3-one compound and intermediate therefor |
11/29/2006 | EP1726584A1 2-aminoquinazoline derivative |
11/29/2006 | EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1 |
11/29/2006 | EP1726580A1 Aminophenylpropanoic acid derivative |
11/29/2006 | EP1726313A1 Drug for preventing and treating arteriosclerosis |
11/29/2006 | EP1726310A1 Medicine for cancer therapy |
11/29/2006 | EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
11/29/2006 | EP1480624B1 Pharmaceutical tablet |
11/29/2006 | EP1411989A4 Methods for improving cell line activity in immunoisolation devices |
11/29/2006 | EP1313504B1 Methods and compositions for inhibiting angiogenesis |
11/29/2006 | EP1259223A4 Protein matrix materials, devices and methods of making and using thereof |
11/29/2006 | EP1248804B1 Recombinant antibodies to human interleukin-1 beta |
11/29/2006 | EP1248604B1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
11/29/2006 | EP1220911B1 P-glycoproteins and uses thereof |
11/29/2006 | EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
11/29/2006 | EP1196598B1 Dsp-3 dual-specificity phosphatase |
11/29/2006 | EP1117692B1 Tie2 agonist antibodies |
11/29/2006 | EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion |
11/29/2006 | EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
11/29/2006 | EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents |
11/29/2006 | EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide |
11/29/2006 | EP0738149B1 1-aminoindan derivatives and compositions thereof |
11/29/2006 | EP0699194B1 5-ht4 receptor antagonists |
11/29/2006 | CN1871347A Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in |
11/29/2006 | CN1871240A Pyrrolopyrimidine thion derivatives |
11/29/2006 | CN1871030A Method of inhibiting secretase activity |
11/29/2006 | CN1870983A Compositions and foods for improving lipid metabolism |
11/29/2006 | CN1869061A Peptidomimetic protease inhibitors |
11/29/2006 | CN1868525A Medicine for retarding human senility and its prepn. method |
11/29/2006 | CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
11/29/2006 | CN1868480A Methods for inhibiting cognitive deterioration in adults with down's syndrome |
11/29/2006 | CN1868461A Tegaserod maleate oral prepn. |
11/29/2006 | CN1868458A Controlled release composition and method of producing the same |
11/29/2006 | CN1286976C Interferon-alpha/beta binding protein, its preparation and use |
11/29/2006 | CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
11/29/2006 | CN1286839C Fermentation preparation method of cell inhibitor and its crystal form |
11/29/2006 | CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/29/2006 | CN1286834C Benzothiazoles compound |
11/29/2006 | CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor |
11/29/2006 | CN1286822C Pyrimidinone compounds |
11/29/2006 | CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
11/29/2006 | CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound |
11/29/2006 | CN1286812C Bispiperidines as antithrombotic agents |
11/29/2006 | CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents |
11/29/2006 | CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy |
11/29/2006 | CN1286523C Chinese medicinal pill of human body air activity smooth |
11/29/2006 | CN1286515C Medicinal composition for treating cyst |
11/29/2006 | CN1286491C Preparation for sobering use |
11/29/2006 | CN1286469C Pharmaceutical use of isolarisiresinol |
11/29/2006 | CN1286456C Luolai compositions useful for the treatment of type-2 synalbumin diabetes pharmaceutical application |
11/29/2006 | CN1286455C Pharmaceutical use of 5-hydroxymethyl furfural |
11/28/2006 | US7142910 Methods of indirectly stimulating the vagus nerve with an electrical field |
11/28/2006 | US7141656 In situ screening, isolation of peptides; major histocompability complex |
11/28/2006 | US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders |
11/28/2006 | US7141598 Imidazole derivatives, production method thereof and use thereof |
11/28/2006 | US7141582 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders |
11/28/2006 | US7141580 activity as prostaglandin E2 receptor antagonists |
11/28/2006 | US7141576 4-quinazolineamine derivatives; antineoplastic agents; inhibitors of erb family tyrosine kinases and/or epidermal growth factor receptors |
11/28/2006 | US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
11/28/2006 | US7141574 Viral polymerase inhibitors |
11/28/2006 | US7141573 Huntington's diseases, Alzheimer's diseases, psychological disorders |
11/28/2006 | US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
11/28/2006 | US7141560 For use as analgesic or sedative; treating sleep disorders |
11/28/2006 | US7141557 Lipid analogs for treating viral infections |
11/28/2006 | US7141554 Method of treating irritable bowel syndrome |
11/28/2006 | US7141545 Osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level |
11/28/2006 | US7141409 Hyaluronan synthase gene and uses thereof |
11/28/2006 | US7141383 EDG8 receptor, its preparation and use |
11/28/2006 | US7141365 Methods for diagnosing a mucin production associated disease condition |
11/28/2006 | US7141363 Purposeful movement of human migratory cells away from an agent source |
11/28/2006 | CA2379786C Purine derivatives |
11/28/2006 | CA2379640C Certain alkylene diamine-substituted heterocycles |
11/28/2006 | CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
11/28/2006 | CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
11/28/2006 | CA2275379C Use of pramipexole in the treatment of restless legs syndrome |
11/28/2006 | CA2222311C Use of at least one beta-adrenergic agonist as a p substance antagonist |
11/28/2006 | CA2167525C Fungicidal methods and compositions for killing yeast and sporular microorganisms |
11/28/2006 | CA2160444C Aroyl-piperdine derivatives |
11/28/2006 | CA2137203C Protein kinase c inhibitors |
11/23/2006 | WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
11/23/2006 | WO2006123817A1 Method for delivering nucleic acid and device for delivering nucleic acid |
11/23/2006 | WO2006123726A1 Pharmaceutical composition |
11/23/2006 | WO2006123725A1 Pyrrolidine derivative or salt thereof |
11/23/2006 | WO2006123724A1 Novel pharmaceutical using anti-hla antibody |
11/23/2006 | WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
11/23/2006 | WO2006123639A1 Pyrimidine derivative |
11/23/2006 | WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses |
11/23/2006 | US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one; |
11/23/2006 | US20060264630 Antidiabetic agents; modulate insulin drug resistance |
11/23/2006 | US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay |
11/23/2006 | US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide |
11/23/2006 | US20060264517 Methods of reducing microbial resistance to drugs |